Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: The role of 18F-FDG PET/CT

Gynecologic Oncology

Volumn 130, Issue 2, 2013, Pages 306-311

  Crivellaro, Cinzia ^a,b   Signorelli, Mauro ^b   Guerra, Luca ^b   De Ponti, Elena ^b   Pirovano, Cecilia ^b   Fruscio, Robert ^b   Elisei, Federica ^b   Montanelli, Luca ^b   Buda, Alessandro ^b   Messa, Cristina ^a,b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

Author keywords

PET CT Endometrial cancer High risk Staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURGERY; CLINICAL EVALUATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; EARLY CANCER; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; GLYCOLYSIS; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT CANCER; SALPINGOOOPHORECTOMY;

ENDOMETRIAL CANCER; HIGH-RISK; PET/CT; STAGING;

AGED; ENDOMETRIAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TUMOR BURDEN;

EID: 84880315143     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.05.011     Document Type: Article

References (49)

1. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74 108
2. H.M. Keys, J.A. Roberts, V.L. Brunetto, R.J. Zaino, N.M. Spirtos, and J.D. Bloss A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study Gynecol Oncol 92 2004 744 751
3. C.L. Creutzberg, W.L. van Putten, P.C. Koper, M.L. Lybeert, J.J. Jobsen, and C.C. Warlam-Rodenhuis Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma Lancet 355 2000 1404 1411
4. W.T. Creasman, M.F. Kohler, F. Odicino, P. Maisonneuve, and P. Boyle Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium Gynecol Oncol 95 2004 593 596
5. C.L. Creutzberg, W.L. van Putten, C.C. Warlam-Rodenhuis, A.C. van den Bergh, K.A. de Winter, and P.C. Koper Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial J Clin Oncol 22 2004 1234 1241
6. A. Jemal, T. Murray, E. Ward, A. Samuels, R.C. Tiwari, and A. Ghafoor Cancer statistics, 2005 CA Cancer J Clin 55 2005 10 30
7. P.J. Frederick, and J.M. Straughn Jr. The role of comprehensive surgical staging in patients with endometrial cancer Cancer Control 16 2009 23 29
8. S.N. Lewin, T.J. Herzog, N.I. Barrena Medel, I. Deutsch, W.M. Burke, and X. Sun Comparative performance of the 2009 international Federation of gynecology and obstetrics' staging system for uterine corpus cancer Obstet Gynecol 116 2010 1141 1149
9. M.Q. Bernardini, and J.K. Murphy Issues surrounding lymphadenectomy in the management of endometrial cancer J Surg Oncol 99 2009 232 241
10. J.K. Chan, M.K. Cheung, W.K. Huh, K. Osann, A. Husain, and N.N. Teng Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients Cancer 107 2006 1823 1830
11. J.K. Chan, and D.S. Kapp Role of complete lymphadenectomy in endometrioid uterine cancer Lancet Oncol 8 2007 831 841
12. J.K. Chan, H. Wu, M.K. Cheung, J.Y. Shin, K. Osann, and D.S. Kapp The outcomes of 27,063 women with unstaged endometrioid uterine cancer Gynecol Oncol 106 2007 282 288
13. R. Seracchioli, S. Solfrini, M. Mabrouk, C. Facchini, N. Di Donato, and L. Manuzzi Controversies in surgical staging of endometrial cancer Obstet Gynecol Int 2010 2010 181963
14. H. Kitchener, A.M. Swart, Q. Qian, C. Amos, and M.K. Parmar Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study Lancet 373 2009 125 136
15. P. Benedetti Panici, S. Basile, F. Maneschi, A. Alberto Lissoni, M. Signorelli, and G. Scambia Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial J Natl Cancer Inst 100 2008 1707 1716
16. J.M. Cragun, L.J. Havrilesky, B. Calingaert, I. Synan, A.A. Secord, and J.T. Soper Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer J Clin Oncol 23 2005 3668 3675
17. M. Signorelli, L. Guerra, A. Buda, M. Picchio, G. Mangili, and T. Dell'Anna Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: detection of pelvic nodal metastases Gynecol Oncol 115 2009 231 235
18. T. Suga, Y. Nakamoto, T. Saga, T. Higashi, Y. Hamanaka, and M. Tatsumi Clinical value of FDG-PET for preoperative evaluation of endometrial cancer Ann Nucl Med 25 2011 269 275
19. M. Picchio, G. Mangili, A.M. Samanes Gajate, P. De Marzi, E.G. Spinapolice, and P. Mapelli High-grade endometrial cancer: value of [(18)F]FDG PET/CT in preoperative staging Nucl Med Commun 31 2010 506 512
20. E. Inubashiri, K. Hata, K. Kanenishi, A. Shiota, M. Ohno, and Y. Yamamoto Positron emission tomography with the glucose analog [F]-fluoro-2-deoxy-D- glucose for evaluating pelvic lymph node metastasis in uterine corpus cancer: comparison with CT and MRI findings J Obstet Gynaecol Res 35 2009 26 34
21. K. Nakamura, J. Kodama, Y. Okumura, A. Hongo, S. Kanazawa, and Y. Hiramatsu The SUVmax of 18F-FDG PET correlates with histological grade in endometrial cancer Int J Gynecol Cancer 20 2010 110 115
22. K. Kitajima, K. Murakami, E. Yamasaki, I. Fukasawa, N. Inaba, and Y. Kaji Accuracy of 18F-FDG PET/CT in detecting pelvic and paraaortic lymph node metastasis in patients with endometrial cancer AJR Am J Roentgenol 190 2008 1652 1658
23. N.S. Horowitz, F. Dehdashti, T.J. Herzog, J.S. Rader, M.A. Powell, and R.K. Gibb Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer Gynecol Oncol 95 2004 546 551
24. W. Park, Y.J. Park, S.J. Huh, B.G. Kim, D.S. Bae, and J. Lee The usefulness of MRI and PET imaging for the detection of parametrial involvement and lymph node metastasis in patients with cervical cancer Jpn J Clin Oncol 35 2005 260 264
25. A. Chao, T.C. Chang, K.K. Ng, S. Hsueh, H.J. Huang, and H.H. Chou 18F-FDG PET in the management of endometrial cancer Eur J Nucl Med Mol Imaging 33 2006 36 44
26. M.C. Chang, J.H. Chen, J.A. Liang, K.T. Yang, K.Y. Cheng, and C.H. Kao 18F-FDG PET or PET/CT for detection of metastatic lymph nodes in patients with endometrial cancer: A systematic review and meta-analysis Eur J Radiol 81 2012 3511 3517
27. K. Nakamura, A. Hongo, J. Kodama, and Y. Hiramatsu The measurement of SUVmax of the primary tumor is predictive of prognosis for patients with endometrial cancer Gynecol Oncol 123 2011 82 87
28. K. Kitajima, M. Kita, K. Suzuki, M. Senda, Y. Nakamoto, and K. Sugimura Prognostic significance of SUVmax (maximum standardized uptake value) measured by [(18)F]FDG PET/CT in endometrial cancer Eur J Nucl Med Mol Imaging 39 2012 840 845
29. S.H. Hyun, J.Y. Choi, Y.M. Shim, K. Kim, S.J. Lee, and Y.S. Cho Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma Ann Surg Oncol 17 2010 115 122
30. M.K. Chung, H.S. Jeong, Y.I. Son, Y.K. So, G.Y. Park, and J.Y. Choi Metabolic tumor volumes by [18F]-fluorodeoxyglucose PET/CT correlate with occult metastasis in oral squamous cell carcinoma of the tongue Ann Surg Oncol 16 2009 3111 3117
31. H.H. Chung, J.W. Kim, K.H. Han, J.S. Eo, K.W. Kang, and N.H. Park Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer Gynecol Oncol 120 2011 270 274
32. R.N. Moule, I. Kayani, T. Prior, C. Lemon, K. Goodchild, and B. Sanghera Adaptive 18fluoro-2-deoxyglucose positron emission tomography/computed tomography-based target volume delineation in radiotherapy planning of head and neck cancer Clin Oncol (R Coll Radiol) 23 2011 364 371
33. C. Crivellaro, M. Signorelli, L. Guerra, E. De Ponti, A. Buda, and C. Dolci 18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer Gynecol Oncol 127 2012 131 135
34. H. Hricak, L.V. Rubinstein, G.M. Gherman, and N. Karstaedt MR imaging evaluation of endometrial carcinoma: results of an NCI cooperative study Radiology 179 1991 829 832
35. R. Manfredi, B. Gui, G. Maresca, F. Fanfani, and L. Bonomo Endometrial cancer: magnetic resonance imaging Abdom Imaging 30 2005 626 636
36. J.P. Connor, J.I. Andrews, B. Anderson, and R.E. Buller Computed tomography in endometrial carcinoma Obstet Gynecol 95 2000 692 696
37. T. Sugiyama, T. Nishida, K. Ushijima, N. Sato, A. Kataoka, and K. Imaishi Detection of lymph node metastasis in ovarian carcinoma and uterine corpus carcinoma by preoperative computerized tomography or magnetic resonance imaging J Obstet Gynaecol (Tokyo 1995) 21 1995 551 556
38. A.G. Rockall, S.A. Sohaib, M.G. Harisinghani, S.A. Babar, N. Singh, and A.R. Jeyarajah Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer J Clin Oncol 23 2005 2813 2821
39. A.G. Rockall, R. Meroni, S.A. Sohaib, K. Reynolds, F. Alexander-Sefre, and J.H. Shepherd Evaluation of endometrial carcinoma on magnetic resonance imaging Int J Gynecol Cancer 17 2007 188 196
40. M.L. Berman, S. Bergen, and H. Salazar Influence of histological features and treatment on the prognosis of patients with cervical cancer metastatic to pelvic lymph nodes Gynecol Oncol 39 1990 127 131
41. R.C. Boronow, C.P. Morrow, W.T. Creasman, P.J. Disaia, S.G. Silverberg, and A. Miller Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study Obstet Gynecol 63 1984 825 832
42. W.T. Creasman, C.P. Morrow, B.N. Bundy, H.D. Homesley, J.E. Graham, and P.B. Heller Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study Cancer 60 1987 2035 2041
43. D. Gal, F.O. Recio, D. Zamurovic, and M.L. Tancer Lymphovascular space involvement - a prognostic indicator in endometrial adenocarcinoma Gynecol Oncol 42 1991 142 145
44. D.M. Larson, G.P. Connor, S.K. Broste, B.R. Krawisz, and K.K. Johnson Prognostic significance of gross myometrial invasion with endometrial cancer Obstet Gynecol 88 1996 394 398
45. F.Y. Liu, A. Chao, C.H. Lai, H.H. Chou, and T.C. Yen Metabolic tumor volume by 18F-FDG PET/CT is prognostic for stage IVB endometrial carcinoma Gynecol Oncol 125 2012 566 571
46. J.R. Lurain, B.L. Rice, A.W. Rademaker, L.E. Poggensee, J.C. Schink, and D.S. Miller Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium Obstet Gynecol 78 1991 63 69
47. A. Mariani, M.J. Webb, G.L. Keeney, T.G. Lesnick, and K.C. Podratz Surgical stage I endometrial cancer: predictors of distant failure and death Gynecol Oncol 87 2002 274 280
48. C. Shah, E.B. Johnson, E. Everett, H. Tamimi, B. Greer, and E. Swisher Does size matter? Tumor size and morphology as predictors of nodal status and recurrence in endometrial cancer Gynecol Oncol 99 2005 564 570
49. R.C. Boronow Endometrial cancer and lymph node surgery: the spins continue - a case for reason Gynecol Oncol 111 2008 3 6